Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice

Qiong Liu1,2,3, Siying Cheng1,2, Huiming Yang2

  • 1Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, China.

Insights

Depleting Hap1 in Huntington disease (HD) mice caused striatal neuron loss, requiring mutant huntingtin (HTT). This suggests Hap1 and Rhes contribute to selective neurodegeneration in HD.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington disease (HD) is characterized by selective neurodegeneration in the striatum.
  • This neurodegeneration is linked to expanded polyglutamine (polyQ) repeats in the huntingtin (HTT) protein.

Purpose of the Study:

  • To investigate the role of Hap1 (huntingtin-associated protein 1) in selective neurodegeneration in HD.
  • To explore the interaction between Hap1, mutant HTT, and Rhes in HD pathogenesis.

Main Methods:

  • Adeno-associated virus (AAV) mediated depletion of Hap1 in adult HD knock-in (KI) mouse brains.
  • Analysis of neuronal loss in the striatum.
  • Investigation of Rhes binding to N-terminal HTT and HTT sumoylation.

Main Results:

  • AAV-mediated Hap1 depletion in HD KI mice resulted in selective striatal neuronal loss.
  • This neuronal loss was dependent on the presence of mutant HTT.
  • Hap1 deficiency led to increased binding of Rhes to N-terminal HTT and enhanced HTT sumoylation.

Conclusions:

  • Hap1 plays a crucial role in protecting striatal neurons in the context of HD.
  • The interplay between Hap1, Rhes, and mutant HTT contributes to selective neurodegeneration in HD.
  • Multiple factors, including cellular stress, are involved in the complex mechanisms of HD neurodegeneration.